SCHEMBL31545136

SCHEMBL31545136

Cc1cc(-c2ccc(O)c(C)c2O)c(C)c(C)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.41
ESR2 Q92731 9/20 0.41
MAPT P10636 3/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
G6PD P11413 1/20 0.37
CYP2C9 P11712 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
CCR6 P51684 1/20 0.37
HIF1A Q16665 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176388 0.82 CA1 (0.48) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL11802995 0.82 ESR1 (0.46) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL29429119 0.82 CA1 (0.48) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL18948599 0.77 LMNA (0.43) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL15511736 0.75 ESR2 (0.54) ESR1ESR2MAPTALDH1A1CYP2C9
SCHEMBL16424027 0.75 ALDH1A1 (0.61) MAPTKDM4EALDH1A1CYP3A4G6PD
Ethane SCHEMBL28075450 0.74 LMNA (0.42) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL8828331 0.74 ELANE (0.41) MAPTKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL17060497 0.74 CA1 (0.46) ESR1ESR2MAPTKDM4EALDH1A1
SCHEMBL2860152 0.73 TRPA1 (0.46) ESR1ESR2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed